Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$45.08+0.54 (+1.21%)
Close on Nov 17, 2026Market cap $5.49BP/E –Yield –
Scholar Rock total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Scholar Rock's total debt was $196.20M at Jun 30, 2026. For fiscal 2025 it was $99.71M, up 98.8% from the year before. The highest annual figure on record is $99.71M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.71M | +98.8% |
| FY2024 | Dec 31, 2024 | $50.15M | +0.3% |
| FY2023 | Dec 31, 2023 | $50.02M | +0.6% |
| FY2022 | Dec 31, 2022 | $49.74M | -0.5% |
| FY2021 | Dec 31, 2021 | $50.00M | +102.6% |
| FY2020 | Dec 31, 2020 | $24.68M | +5242.0% |
| FY2018 | Dec 31, 2018 | $462.00K | -55.5% |
| FY2017 | Dec 31, 2017 | $1.04M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $196.20M | +294.3% |
| Q1 FY2026 | Mar 31, 2026 | $196.61M | +295.3% |
| Q4 FY2025 | Dec 31, 2025 | $99.71M | +98.8% |
| Q3 FY2025 | Sep 30, 2025 | $99.61M | +98.8% |
| Q2 FY2025 | Jun 30, 2025 | $49.76M | -0.6% |
| Q1 FY2025 | Mar 31, 2025 | $49.74M | -0.7% |
| Q4 FY2024 | Dec 31, 2024 | $50.15M | +0.3% |
| Q3 FY2024 | Sep 30, 2024 | $50.10M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $50.07M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | $50.10M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | $50.02M | +0.6% |
| Q3 FY2023 | Sep 30, 2023 | $49.96M | -1.2% |
| Q2 FY2023 | Jun 30, 2023 | $49.90M | -1.0% |
| Q1 FY2023 | Mar 31, 2023 | $49.83M | -0.7% |
| Q4 FY2022 | Dec 31, 2022 | $49.74M | -0.5% |
| Q3 FY2022 | Sep 30, 2022 | $50.57M | +102.9% |
| Q2 FY2022 | Jun 30, 2022 | $50.39M | +102.8% |
| Q1 FY2022 | Mar 31, 2022 | $50.20M | +102.7% |
| Q4 FY2021 | Dec 31, 2021 | $50.00M | +102.6% |
| Q3 FY2021 | Sep 30, 2021 | $24.93M | +5295.7% |
| Q2 FY2021 | Jun 30, 2021 | $24.85M | +4198.8% |
| Q1 FY2021 | Mar 31, 2021 | $24.76M | +3287.6% |
| Q4 FY2020 | Dec 31, 2020 | $24.68M | +2275.4% |
| Q4 FY2018 | Dec 31, 2018 | $462.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $578.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $731.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $1.04M | – |
See a number that looks wrong?